These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24916368)

  • 101. Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?
    Battistoni A; Volpe M
    Eur Cardiol; 2020 Feb; 15():e21. PubMed ID: 32419852
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Are the antagonists of the renin-angiotensin system also anticancer agents?
    Lonati C; Morganti A
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):99-102. PubMed ID: 24916368
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Angiotensin inhibition and malignancies: a review.
    Rosenthal T; Gavras I
    J Hum Hypertens; 2009 Oct; 23(10):623-35. PubMed ID: 19339998
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Renin-angiotensin system and cardiovascular risk.
    Strauss MH; Hall A
    Lancet; 2007 Jul; 370(9581):23-4; author reply 24-5. PubMed ID: 17617258
    [No Abstract]   [Full Text] [Related]  

  • 105. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
    Borghi C; ; Rossi F;
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Inhibitors of the renin angiotensin system: proven benefits, unproven safety.
    Parfrey PS
    Ann Intern Med; 2008 Jan; 148(1):76-7. PubMed ID: 17984483
    [No Abstract]   [Full Text] [Related]  

  • 107. Noncommunicable diseases.
    Hunter DJ; Reddy KS
    N Engl J Med; 2013 Oct; 369(14):1336-43. PubMed ID: 24088093
    [No Abstract]   [Full Text] [Related]  

  • 108. Angiotensin receptor blockers: are they related to lung cancer?
    Rao GA; Mann JR; Shoaibi A; Pai SG; Bottai M; Sutton SS; Haddock KS; Bennett CL; Hebert JR
    J Hypertens; 2013 Aug; 31(8):1669-75. PubMed ID: 23822929
    [TBL] [Abstract][Full Text] [Related]  

  • 109. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
    Mancia G; Fagard R; Narkiewicz K; Redón J; Zanchetti A; Böhm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F;
    J Hypertens; 2013 Jul; 31(7):1281-357. PubMed ID: 23817082
    [No Abstract]   [Full Text] [Related]  

  • 110. How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy?
    Kim ST; Park KH; Oh SC; Seo JH; Kim JS; Shin SW; Kim YH
    Oncology; 2012; 83(6):354-60. PubMed ID: 23052034
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review.
    Mc Menamin ÚC; Murray LJ; Cantwell MM; Hughes CM
    Cancer Causes Control; 2012 Feb; 23(2):221-30. PubMed ID: 22116540
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Use of angiotensin receptor blockers and the risk of cancer.
    Pasternak B; Svanström H; Callréus T; Melbye M; Hviid A
    Circulation; 2011 Apr; 123(16):1729-36. PubMed ID: 21482967
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care.
    Ford ES; Capewell S
    Annu Rev Public Health; 2011; 32():5-22. PubMed ID: 21417752
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.
    ARB Trialists Collaboration
    J Hypertens; 2011 Apr; 29(4):623-35. PubMed ID: 21358417
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
    Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
    Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
    [TBL] [Abstract][Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.